Lascoña, Niviana Colene .

HRN: 27-15-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2026
CEFUROXIME 750MG (VIAL)
01/09/2026
01/16/2026
IV
315 MG
Q8HRS
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines